388 related articles for article (PubMed ID: 19795982)
1. iPS cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin.
Yan X; Qin H; Qu C; Tuan RS; Shi S; Huang GT
Stem Cells Dev; 2010 Apr; 19(4):469-80. PubMed ID: 19795982
[TBL] [Abstract][Full Text] [Related]
2. Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts.
Wada N; Wang B; Lin NH; Laslett AL; Gronthos S; Bartold PM
J Periodontal Res; 2011 Aug; 46(4):438-47. PubMed ID: 21443752
[TBL] [Abstract][Full Text] [Related]
3. Porcine induced pluripotent stem cells produce chimeric offspring.
West FD; Terlouw SL; Kwon DJ; Mumaw JL; Dhara SK; Hasneen K; Dobrinsky JR; Stice SL
Stem Cells Dev; 2010 Aug; 19(8):1211-20. PubMed ID: 20380514
[TBL] [Abstract][Full Text] [Related]
4. Inducing pluripotency in somatic cells from the snow leopard (Panthera uncia), an endangered felid.
Verma R; Holland MK; Temple-Smith P; Verma PJ
Theriogenology; 2012 Jan; 77(1):220-8, 228.e1-2. PubMed ID: 22079579
[TBL] [Abstract][Full Text] [Related]
5. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
Okada M; Yoneda Y
Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming adipose tissue-derived mesenchymal stem cells into pluripotent stem cells by a mutant adeno-associated viral vector.
Chen MJ; Lu Y; Hamazaki T; Tsai HY; Erger K; Conlon T; Elshikha AS; Li H; Srivastava A; Yao C; Brantly M; Chiodo V; Hauswirth W; Terada N; Song S
Hum Gene Ther Methods; 2014 Feb; 25(1):72-82. PubMed ID: 24191859
[TBL] [Abstract][Full Text] [Related]
7. Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors.
Deng Y; Liu Q; Luo C; Chen S; Li X; Wang C; Liu Z; Lei X; Zhang H; Sun H; Lu F; Jiang J; Shi D
Stem Cells Dev; 2012 Sep; 21(13):2485-94. PubMed ID: 22420535
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming in vivo produces teratomas and iPS cells with totipotency features.
Abad M; Mosteiro L; Pantoja C; Cañamero M; Rayon T; Ors I; Graña O; Megías D; Domínguez O; Martínez D; Manzanares M; Ortega S; Serrano M
Nature; 2013 Oct; 502(7471):340-5. PubMed ID: 24025773
[TBL] [Abstract][Full Text] [Related]
9. Nuclear reprogramming with a non-integrating human RNA virus.
Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
[TBL] [Abstract][Full Text] [Related]
10. ONSL and OSKM cocktails act synergistically in reprogramming human somatic cells into induced pluripotent stem cells.
Jung L; Tropel P; Moal Y; Teletin M; Jeandidier E; Gayon R; Himmelspach C; Bello F; André C; Tosch A; Mansouri A; Bruant-Rodier C; Bouillé P; Viville S
Mol Hum Reprod; 2014 Jun; 20(6):538-49. PubMed ID: 24501429
[TBL] [Abstract][Full Text] [Related]
11. Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics.
Moschidou D; Mukherjee S; Blundell MP; Jones GN; Atala AJ; Thrasher AJ; Fisk NM; De Coppi P; Guillot PV
Stem Cells Dev; 2013 Feb; 22(3):444-58. PubMed ID: 23050522
[TBL] [Abstract][Full Text] [Related]
12. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
[TBL] [Abstract][Full Text] [Related]
13. Generating induced pluripotent stem cells from common marmoset (Callithrix jacchus) fetal liver cells using defined factors, including Lin28.
Tomioka I; Maeda T; Shimada H; Kawai K; Okada Y; Igarashi H; Oiwa R; Iwasaki T; Aoki M; Kimura T; Shiozawa S; Shinohara H; Suemizu H; Sasaki E; Okano H
Genes Cells; 2010 Sep; 15(9):959-69. PubMed ID: 20670273
[TBL] [Abstract][Full Text] [Related]
14. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
[TBL] [Abstract][Full Text] [Related]
15. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
16. Human-induced pluripotent stem cells produced under xeno-free conditions.
Ross PJ; Suhr ST; Rodriguez RM; Chang EA; Wang K; Siripattarapravat K; Ko T; Cibelli JB
Stem Cells Dev; 2010 Aug; 19(8):1221-9. PubMed ID: 20030562
[TBL] [Abstract][Full Text] [Related]
17. Generation of clinically relevant "induced pluripotent stem" (iPS) cells.
Heffernan C; Sumer H; Verma PJ
J Stem Cells; 2011; 6(3):109-27. PubMed ID: 23264997
[TBL] [Abstract][Full Text] [Related]
18. OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition.
Teshigawara R; Hirano K; Nagata S; Ainscough J; Tada T
Development; 2016 Jan; 143(1):15-23. PubMed ID: 26657769
[TBL] [Abstract][Full Text] [Related]
19. Efficient induction of pluripotent stem cells from granulosa cells by Oct4 and Sox2.
Mao J; Zhang Q; Ye X; Liu K; Liu L
Stem Cells Dev; 2014 Apr; 23(7):779-89. PubMed ID: 24083387
[TBL] [Abstract][Full Text] [Related]
20. Tbx3 improves the germ-line competency of induced pluripotent stem cells.
Han J; Yuan P; Yang H; Zhang J; Soh BS; Li P; Lim SL; Cao S; Tay J; Orlov YL; Lufkin T; Ng HH; Tam WL; Lim B
Nature; 2010 Feb; 463(7284):1096-100. PubMed ID: 20139965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]